Workout
Healthy Eating Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process Contact Us
Health Tracker
AI Tools
✔Fact Checked

The renewals of Pedri and Gavi at Barcelona could suffer a great delay

Article Updated On:
Photo of author
FitToFar
Published On:

Barcelona has been in talks for several months with Pedri and Gavi’s representation about new contracts. However, they may experience significant delays.

Sport details that Barcelona is waiting for a court decision on the signings of Dani Olmo and Pau Víctor, but if it goes against them, they will have to sell more assets to be able to play in the second half of the season. However, if they don’t, Barcelona will be forced to delay Gavi and Pedri’s contracts.

This sale of assets will have a value of at least 120 million euros and would allow the Blaugrana to fit these new agreements into their salary limit. Otherwise, they will be forced to wait until summer.

Given all the noise coming out of the club and the local media having been positive that both want to stay at the club, it seems unlikely to become a major issue for either of their futures. However, it could have a knock-on impact on their ability to award new contracts to players such as Ronald Araujo and Frenkie de Jong, who, like Pedri and Gavi, are signed until 2026.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

Read This Next


dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.

 

SHARE YOUR FEEDBACK

SHARE YOUR FEEDBACK